In a recent clinical trial of adults with Type 1 diabetes, the inhaled insulin Afrezza delivered similar HbA1c reductions compared to usual care,...

A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar and leads to substantial...

A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar and leads to substantial...

FRIDAY, June 27, 2025 -- Once-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated...

FRIDAY, June 27, 2025 -- Once-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated...

INDIANAPOLIS, June 21, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced detailed results from ACHIEVE-1, a Phase 3 trial...

A promising new alternative to insulin injections is several months away from being trialled on people with diabetes.

A promising new alternative to insulin injections is several months away from being trialled on people with diabetes.

A promising new alternative to insulin injections is several months away from being trialled on people with diabetes.

A promising new alternative to insulin injections is several months away from being trialled on people with diabetes.